Polydex Pharmaceuticals Ltd. (OTC: POLXF) CEO Interview with George Usher, discussing the company's specialty chemical business which supplies dextran products to pharmaceutical manufacturers worldwide. Topics discussed include, overview of global market for dextran, and ongoing growth initiatives.
This content is available to members only.
If you are an existing member, please LOGIN
Note a member? Sign up for a FREE trial account ($195 per month value), and get immediate access. Free offer expires June 15, 2019.
Register New Account
Institutional / team access subscriptions, contact Melissa Walters 212-871-2057 ext 2